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The relationship between migraine and psychopathology
has been clinically discussed in various studies. Medica-
tion-overuse headache (MOH) has been often found
comorbid with emotional disturbances and disordered
personality traits [1,2]. This might play a role in the evo-
lution of migraine to MOH and might be associated
with higher risks of chronicization and/or relapses in
drug abuse. Psychological disturbances may also be risk
factors for a later development of MOH [3]. Since 2012
the Psychology Service of Sant’Andrea Regional Referral
Headache Centre has offered short cycles of psychologi-
cal interviews mostly oriented towards the support of
MOH patients during the post-rehabilitation infusional
phase in order to prevent relapses.
In these past 3 years 106 MOH patients afferent to the
Headache Centre underwent the infusional therapy and
were eligible for psychological support. Patients’ profiles
highlighted avoidant and dependent personality traits
together with a high level of anxiety and depressive mood.
Patients showed a low perception of their personal skill,
resources and a perception of their body mostly related to
the head pain. The psychological intervention has been
cognitive-behavioral and has improved patients’ percep-
tion of self relative to their body, their personal skills and
resources.
Psychological support together with prophylaxis ther-
apy with OnabotulinumtoxinA produced in patients a
reduction of relapses in drug abuse of 38% compared to
a sample of 108 patients age and gender matched that
was not eligible for psychological support but received
the detoxification and prophylaxis therapy.
This means that in some selected cases a multimodal
therapy, consisting in a program of pharmacotherapy and
psychological support, is necessary for the treatment of
MOH patients in order to reduce the risks of relapses
into drug abuse.
Written informed consent to publish was obtained
from the patient(s).
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